CUREDirexion Daily Healthcare Bull 3X Shares
Seeks daily investment results of 300% of the performance of the Health Care Select Sector Index.
By Direxion Funds · Launched 2011
0.94%
#4,588 of 5,562 · expensive
$156M
#2,523 of 5,562 · mid-size
+24.4%
15 years
#899 of 5,562 · established
Performance
Total-return NAV · USDTotal-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundAsset class
EquityRegion
North americaStrategy
Leveraged
Sector
Health careIndex tracked
Health Care Select Sector Index
What it actually holds
By weightConcentration
Top 10 holdings = 69.1% of fundconcentrated
Asset allocation
By sector
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsYear-on-year price swings
Worst peak-to-trough loss
Where to buy
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks daily investment results of 300% of the performance of the Health Care Select Sector Index.
- Strategy
- Invests primarily in financial instruments that provide 3x leveraged exposure to the Health Care Select Sector Index. Designed for daily trading, the Fund's performance may differ significantly over longer periods due to compounding effects.
- Inception date
- June 15, 2011
- Fund family
- Direxion Funds
Similar ETFs
Closest matches by profileOur take
Structural notes on how this fund behaves. Read our guide on the 6 warning signs.
Leveraged ETF — not a long-term hold
This fund uses leverage to amplify daily returns (e.g. 2x or 3x of an index). Daily rebalancing creates volatility decay — over weeks and months, the fund's return drifts from the stated multiple. In trending markets with low realised volatility, leveraged index ETFs can outperform their nominal multiple; in sideways or volatile markets they bleed. Designed for short-term tactical use, not buy-and-hold.
Source: Cheng & Madhavan, 'The Dynamics of Leveraged and Inverse ETFs' (2009)
Why we flagged this: strategy=leveraged + leveraged_name_or_strategy
Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More
What's next?
You've reviewed CURE. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19